Medtronic has entered into an agreement with Amgen to promote the Prolia device to spine specialists through Medtronic's Interventional Spine division.
The Prolia is for use in postmenopausal women with osteoporosis at a high risk of fractures. Approximately half of women older than 50 will have an osteoporosis-related fracture in their lifetime, according to an HHS study.
The financial terms of the deal were not disclosed.
More Articles on Devices:
8 Recent Leadership & Executive Moves at Spine, Orthopedic Device Companies
FDA Grants Approval to OsteoSelect Putty for Spinal Fusions
Renaissance Spine Guidance Brings 99% Accuracy to 118 Minimally Invasive Procedures in Germany